Skip to main content
Clinical Trials/IRCT2016011626047N1
IRCT2016011626047N1
Completed
Phase 3

Comparison of efficacy and safety of topical Tranexamic Acid with and without using non-ablative fractional Erbium glass in patients with melasma refering to Razi Hospitallaser 1540nm for treatment of melasma in patients referred to Razi hospital

Vice chancellor for research,Tehran University of Medical Science0 sites25 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
melasma.
Sponsor
Vice chancellor for research,Tehran University of Medical Science
Enrollment
25
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research,Tehran University of Medical Science

Eligibility Criteria

Inclusion Criteria

  • inclusion criteria: 18\-65 years; symmetrical melasma in both half of the face; patients' satisfaction; skin type 1\-5
  • exclusion criteria: use hidroquinone, topical and oral retinoid, topical steroid, alfa hydroxy acids and other drugs effect on pigmentation in past 4 weeks; use Oral Conterseptive Pill; chemical peeling,microderm abration, dermabratin or laser in past 3 months; history of past sensitivity to tranexamic acid; pregnancy; lactation; history ischemic or hemorrahgic events of coronal or cerebral artries

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials